Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
Research Highlights
Nature Reviews Clinical Oncology 1, 60 (1 December 2004) | doi:10.1038/ncponc0029
Reduced postoperative chemotherapy for Wilms' tumor
Abstract
de Kraker J et al. (2004) Reduction of postoperative chemotherapy in children with stage I intermediate-risk and anaplastic Wilms' tumour (SIOP 93-01 trial): a randomised controlled trial. Lancet 364: 1229–1235 High rates of recurrence-free and overall survival have been achieved for Wilms' tumor, so the emphasis of current research is on reducing treatment-related toxicity.
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
